EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β‐catenin at Ser552

Hepatocellular carcinoma (HCC) is one of the most common malignancies and the fourth leading cause of cancer‐related death worldwide. Our previous study showed that EYA4 functioned by suppressing growth of HCC tumor cells, but its molecular mechanism is still not elucidated. Based on the results of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Zhu, Xiao‐Xu, Li, Jian‐Hui, Cai, Jian‐Peng, Hou, Xun, Huang, Chen‐Song, Huang, Xi‐Tai, Wang, Jie‐Qin, Li, Shi‐Jin, Xu, Qiong‐Cong, Yin, Xiao‐Yu
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6778622/
https://ncbi.nlm.nih.gov/pubmed/31385398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14159
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars